Correction of Trauma-induced Coagulopathy By Goal Directed Therapy: A Secondary Analysis of the Itactic Trial

Charlotte Lindsay, Ross Davenport, Kjersti Baksaas-Aasen, Knut Magne Kolstadbråten, Pål Aksel Naess, Nicola Curry, Marc Maegele, Nicole Juffermans, Simon Stanworth, Jakob Stensballe, Per Ingemar Johansson, Christine Gaarder, Karim Brohi*

*Corresponding author af dette arbejde
10 Citationer (Scopus)

Abstract

BACKGROUND: Trauma hemorrhage induces a coagulopathy with a high associated mortality rate. The Implementing Treatment Algorithms for the Correction of Trauma Induced Coagulopathy (ITACTIC) randomized trial tested two goal-directed treatment algorithms for coagulation management: one guided by conventional coagulation tests and one by viscoelastic hemostatic assays (viscoelastic). The lack of a difference in 28-day mortality led the authors to hypothesize that coagulopathic patients received insufficient treatment to correct coagulopathy.

METHODS: During ITACTIC, two sites were coenrolling patients into an ongoing prospective observational study, which included serial blood sampling at the same intervals as in ITACTIC. The subgroup in both studies had conventional and viscoelastic test results for each patient available for analysis. A goal-directed treatment was defined as one triggered by an ITACTIC algorithm. Coagulopathy was defined as rotational thromboelastometry EXTEM A5 less than 40 mm. The primary outcome was correction of coagulopathy by the 12th unit of erythrocyte transfusion during resuscitation.

RESULTS: Full viscoelastic and conventional coagulation test results were available for 133 patients. Of these patients, 71% were coagulopathic on admission, and 16% developed a coagulopathy during resuscitation. ITACTIC viscoelastic hemostatic assay group patients were more likely to receive goal-directed treatment than the standard group (76% vs. 47%; odds ratio, 3.73; 95% CI, 1.64 to 8.49; P = 0.002). However, only 54% of patients received goal-directed treatment, and only 20% corrected their coagulopathy (vs. 0% with empiric treatment alone; not significant). Median time to first goal-directed treatment was 68 (53 to 88) min for viscoelastic and 110 (77 to 123) min for standard (P = 0.005).

CONCLUSIONS: In ITACTIC, many bleeding trauma patients did not receive an indicated goal-directed treatment. Interventions arrived late during resuscitation and were only partially effective at correcting coagulopathy.

OriginalsprogEngelsk
Artikelnummer5183
TidsskriftAnesthesiology
Vol/bind141
Udgave nummer5
Sider (fra-til)904-912
Antal sider9
ISSN0003-3022
DOI
StatusUdgivet - 2024

Fingeraftryk

Dyk ned i forskningsemnerne om 'Correction of Trauma-induced Coagulopathy By Goal Directed Therapy: A Secondary Analysis of the Itactic Trial'. Sammen danner de et unikt fingeraftryk.

Citationsformater